By stimulating GLP-1 receptors in the body, these medications can reduce hunger and improve insulin sensitivity, making them highly effective for those focused on weight management and metabolic health
The Medicare GLP-1 Bridge program helps eligible Medicare members access weight-loss GLP-1 medications
While the clinical trials look promising, the long-term safety and efficacy of tirzepatide, especially for weight loss, are still being studied
CVS Caremark has defended its formulary decision as a strategy to promote competition and lower costs, saying an exemption process is in place for medical necessity cases
Journal of Pharmacology and Experimental Therapeutics, 302(3), 881888
Di Giacomo C, Malfa GA, Tomasello B, Bianchi S, Acquaviva R